The generic drug maker's stock climbs by more than 16 percent. Wall Street investors reacted favorably to Teva Pharmaceutical Industries’ decision to abandon its hostile takeover attempt for Mylan NV ...
Shares of Mylan (NYSE:MYL) plunged in Wednesday trading after the company reported disappointing fourth-quarter results. Mylan stock fell as much as 15% as a result and made new 52-week lows. This ...
This Oct. 10, 2013 file photo shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. (AP Photo/Mark Zaleski, File) NEW YORK • Dutch drugmaker Mylan says it will launch a ...
April 27 (Reuters) - Mylan NV rejected Teva Pharmaceutical Industries Ltd's $40 billion takeover offer on Monday, saying in a scathing letter that it grossly undervalued the company and that Mylan has ...
NEW YORK (MarketWatch) -- Mylan Laboratories myl Friday priced an offering of senior convertible notes and common stock that it expects to yield total gross proceeds of $993.6 million.
WASHINGTON (CBS.MW) -- Mylan Laboratories said the Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period in connection with investor Carl Icahn's plan to buy stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results